Burden, Trends and Prediction of NAFLD/MAFLD Attributable to Smoking From 1990 to 2021: GBD 2021 Analysis
Advanced Biology · 2026-04 · 10 (4)
DOI: 10.1002/adbi.202500232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 31.03.2026. Verfasst von Lijuan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Smoking. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Sichuan Province, Basic Research Project of Jiangsu Science and Technology Office.
Abstract (Originalsprache)
Smoking is a risk factor for non‐alcoholic fatty liver disease (NAFLD, recently proposed as metabolic dysfunction‑associated fatty liver disease, MAFLD), but the global smoking‐attributable NAFLD/MAFLD burden remains unclear. Using GBD 2021 data, this study quantified the burden by age, sex, socio‐demographic index (SDI), and region, computed average annual percent changes (AAPC) via Joinpoint regression, and projected 2022–2036 burden using the Bayesian age‐period‐cohort (BAPC) model. During 1990–2021, the AAPC of the age‐standardized DALY rate (ASDR) and mortality rate (ASMR) was 0.0223 [95% uncertainty interval (UI): −0.1432, 0.1880, p = 0.79] and 0.2660 (95%UI: 0.1666, 0.3655, p < 0.001), suggesting that the death‐related burden increased mostly. Notably, males contributed the most to this trend, with the sharpest upward trend recorded in low‐middle SDI regions. Global cross‐country inequality revealed that this death‐related burden is widening, especially among females. In contrast to this historical trajectory, predictive models suggest a steady decline by 2036. In conclusion, global ASMR of smoking‐attributable NAFLD/MAFLD increased during 1990–2021, especially in low‐middle SDI regions and male populations. Despite a projected gradual burden decline over the next 15 years, it still emphasizes the need for strengthened tobacco control and NAFLD/MAFLD prevention in low‐middle SDI regions and male populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
- Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Medford, Massachusetts, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yingyun Gong, Hongwen Zhou
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Sichuan Province
- Basic Research Project of Jiangsu Science and Technology Office
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, L., Zhu, Z., Wang, Y., Guo, L., Fu, Z., Yin, X., Li, J. Z., Gong, Y., & Zhou, H. (2026). Burden, Trends and Prediction of NAFLD/MAFLD Attributable to Smoking From 1990 to 2021: GBD 2021 Analysis. Advanced Biology, 10(4). https://doi.org/10.1002/adbi.202500232
Vancouver
Chen L, Zhu Z, Wang Y, Guo L, Fu Z, Yin X, et al. Burden, Trends and Prediction of NAFLD/MAFLD Attributable to Smoking From 1990 to 2021: GBD 2021 Analysis. Advanced Biology. 2026;10(4). doi:10.1002/adbi.202500232
BibTeX
@article{Chen2026,
author = {Chen, Lijuan and Zhu, Ziyi and Wang, Yishu and Guo, Lin and Fu, Zhenzhen and Yin, Xianyong and Li, John Zhong and Gong, Yingyun and Zhou, Hongwen},
title = {Burden, Trends and Prediction of NAFLD/MAFLD Attributable to Smoking From 1990 to 2021: GBD 2021 Analysis},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {4},
doi = {10.1002/adbi.202500232}
}
EUVIMED